Medicine and science in sports and exercise · 2026
Variations in Estrogen, Progesterone, and Nocturnal Physiology are not Associated with Performance and Sleep within and between Menstrual Cycles.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pearson Madison A, Weakley Jonathon J S, Johnston Rich D, Fernandez Francesca, Munteanu Gabriella, Halson Shona L
Аннотация
PURPOSE: To investigate performance, recovery, sleep, nocturnal physiology, ovarian hormone concentrations, and menstrual cycle symptoms within and between menstrual cycle phases and establish within-phase reliability of these measures.
METHODS: Twenty naturally cycling, trained female participants (age 27 ± 5 yr) completed a repeated measures study design. Serum estradiol and progesterone concentrations, countermovement jumps, isometric mid-thigh pulls, a repeated 5 km cycle time trial, and two nights of sleep architecture were measured in phases one, three, and four of two menstrual cycles. Sleep and wake measures from activity monitoring, nocturnal heart rate (HR) measures from the Oura Ring, and menstrual cycle symptoms were monitored daily. Statistical analyses included linear mixed models and reliability measures.
RESULTS: Estradiol concentrations were significantly lower in phase one versus three, one versus four, and three versus four ( P < 0.001 to 0.04) in both menstrual cycles. Progesterone concentrations were significantly lower in phase one versus four, and three versus four ( P < 0.001) in both menstrual cycles. Symptoms were significantly higher in phase one versus three and four ( P < 0.001) in cycle one only. No significant differences between phases were found for performance, recovery, and sleep in either cycle, except for the nonrapid eye movement stage three (N3%) sleep in cycle two. Nocturnal average HR was significantly lower ( P < 0.001) and HR variability higher ( P < 0.001) in phase one versus four in both cycles. Ovarian hormone concentrations were highly variable within each phase (coefficients of variance 28%-95%), while performance and recovery demonstrated minimal variability in both cycles.
CONCLUSIONS: Performance, recovery, and sleep in trained female participants remained consistent despite ovarian hormone fluctuations. Consequently, practitioners should test athletes when convenient, using accurate and reliable assessments rather than synchronizing testing with specific menstrual cycle phases.
METHODS: Twenty naturally cycling, trained female participants (age 27 ± 5 yr) completed a repeated measures study design. Serum estradiol and progesterone concentrations, countermovement jumps, isometric mid-thigh pulls, a repeated 5 km cycle time trial, and two nights of sleep architecture were measured in phases one, three, and four of two menstrual cycles. Sleep and wake measures from activity monitoring, nocturnal heart rate (HR) measures from the Oura Ring, and menstrual cycle symptoms were monitored daily. Statistical analyses included linear mixed models and reliability measures.
RESULTS: Estradiol concentrations were significantly lower in phase one versus three, one versus four, and three versus four ( P < 0.001 to 0.04) in both menstrual cycles. Progesterone concentrations were significantly lower in phase one versus four, and three versus four ( P < 0.001) in both menstrual cycles. Symptoms were significantly higher in phase one versus three and four ( P < 0.001) in cycle one only. No significant differences between phases were found for performance, recovery, and sleep in either cycle, except for the nonrapid eye movement stage three (N3%) sleep in cycle two. Nocturnal average HR was significantly lower ( P < 0.001) and HR variability higher ( P < 0.001) in phase one versus four in both cycles. Ovarian hormone concentrations were highly variable within each phase (coefficients of variance 28%-95%), while performance and recovery demonstrated minimal variability in both cycles.
CONCLUSIONS: Performance, recovery, and sleep in trained female participants remained consistent despite ovarian hormone fluctuations. Consequently, practitioners should test athletes when convenient, using accurate and reliable assessments rather than synchronizing testing with specific menstrual cycle phases.